PATENT CLAIM ANALYSIS

Application Number: 16399821
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-10
Patent Classification: ["514", "233800"]

Abstract:
The present invention relates generally to therapeutics targeting the bacterium  Porphyromonas gingivalis , including its protease Lysine gingipain (Kgp), and their use for the treatment of disorders associated with  P. gingivalis  infection, including brain disorders such as Alzheimer's disease. In certain embodiments, the invention provides compounds according to Formula I, as described herein, and pharmaceutically acceptable salts thereof.

Claim (Index 56):
The method of  claim 55 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.28302
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14875416', '15996660', '15683348', '12446763', '11431696']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8158664212361637
- 35 USC 102 Novelty (BERT): 0.5833626347800627
- Combined Prediction Score: 0.7926160425905536
- Mean Citation Score: 442.096682
- Max Citation Score: 570.5591400000002
- Similarity Product: 384.1586411216714

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test